Infection of hematopoietic progenitor cells by HIV-1 subtype C, and its association with anemia in southern Africa

被引:33
作者
Redd, Andrew D.
Avalos, Ava
Essex, Max
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Sch Publ Hlth AIDS Initiat, Boston, MA 02115 USA
[2] Botswana Harvard Partnership HIV Educ & Training, Gaborone, Botswana
[3] Princess Marina Hosp, Infect Dis Care Clin, Gaborone, Botswana
关键词
D O I
10.1182/blood-2007-04-086314
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Reports from southern Africa, an area in which human immunodeficiency virus type 1 (HIV-1) infection is caused almost exclusively by subtype C (HIV-1C), have shown increased rates of anemia in HIV-infected populations compared with similar acquired immunodeficiency syndrome (AIDS) patients in the United States, an area predominantly infected with subtype B (HIV-1B). Recent findings by our group demonstrated a direct association between HIV-1 infection and hematopoietic progenitor cell health in Botswana. Therefore, using a single-colony infection assay and quantitative proviral analysis, we examined whether HIV-1C could infect hematopoietic progenitor cells (HPCs) and whether this phenotype was associated with the higher rates of anemia found in southern Africa. The results show that a significant number of HIV-1C, but not HIV-1B, isolates can infect HPCs in vitro (P < .05). In addition, a portion of HIV-1C-positive Africans had infected progenitor cell populations in vivo, which was associated with higher rates of anemia in these patients (P < .05). This represents a difference in cell tropism between 2 geographically separate and distinct HIV-1 subtypes. The association of this hematotropic phenotype with higher rates of anemia should be considered when examining anti-HIV drug treatment regimens in HIV-1C-predominant areas, such as southern Africa.
引用
收藏
页码:3143 / 3149
页数:7
相关论文
共 45 条
[1]   The in vivo effects of combination antiretroviral drug therapy on peripheral blood CD34+ cell colony forming units from HIV type 1 infected patients [J].
Adams, GB ;
Pym, AS ;
Poznansky, MC ;
McClure, MO ;
Weber, JN .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (06) :551-559
[2]  
Adewuyi Jo, 1999, Central African Journal of Medicine, V45, P26
[3]   Infection of human marrow stroma by human immunodeficiency virus-1 (HIV-1) is both required and sufficient for HIV-1-induced hematopoietic suppression in vitro: Demonstration by gene modification of primary human stroma [J].
Bahner, I ;
Kearns, K ;
Coutinho, S ;
Leonard, EH ;
Kohn, DB .
BLOOD, 1997, 90 (05) :1787-1798
[4]   Highly active antiretroviral therapy corrects hematopoiesis in HIV-1 infected patients: interest for peripheral blood stem cell-based gene therapy [J].
Baillou, C ;
Simon, A ;
Leclercq, V ;
Azar, N ;
Rosenzwajg, M ;
Herson, S ;
Klatzmann, D ;
Lemoine, FM .
AIDS, 2003, 17 (04) :563-574
[5]   Human mast cell progenitors can be infected by macrophagetropic human immunodeficiency virus type 1 and retain virus with maturation in vitro [J].
Bannert, N ;
Farzan, M ;
Friend, DS ;
Ochi, H ;
Price, KS ;
Sodroski, J ;
Boyce, JA .
JOURNAL OF VIROLOGY, 2001, 75 (22) :10808-10814
[6]  
BROXMEYER HE, 1986, J IMMUNOL, V136, P4487
[7]   Analysis of early human immunodeficiency virus type 1 DNA synthesis by use of a new sensitive assay for quantifying integrated provirus [J].
Brussel, A ;
Sonigo, P .
JOURNAL OF VIROLOGY, 2003, 77 (18) :10119-10124
[8]   Adverse effects of antiretroviral therapy [J].
Carr, A ;
Cooper, DA .
LANCET, 2000, 356 (9239) :1423-1430
[9]   IN-VITRO HUMAN IMMUNODEFICIENCY VIRUS-1 INFECTION OF PURIFIED HEMATOPOIETIC PROGENITORS IN SINGLE-CELL CULTURE [J].
CHELUCCI, C ;
HASSAN, HJ ;
LOCARDI, C ;
BULGARINI, D ;
PELOSI, E ;
MARIANI, G ;
TESTA, U ;
FEDERICO, M ;
VALTIERI, M ;
PESCHLE, C .
BLOOD, 1995, 85 (05) :1181-1187
[10]   ABSENT OR RARE HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION OF BONE-MARROW STEM PROGENITOR CELLS INVIVO [J].
DAVIS, BR ;
SCHWARTZ, DH ;
MARX, JC ;
JOHNSON, CE ;
BERRY, JM ;
LYDING, J ;
MERIGAN, TC ;
ZANDER, A .
JOURNAL OF VIROLOGY, 1991, 65 (04) :1985-1990